An observational study in Age Group: 65-74 and HIV, sponsored by Centre Hospitalier Universitaire Saint Pierre. Recruiting at 1 site in Belgium. Open to participants aged 65 Years to 74 Years. Per ClinicalTrials.gov, last updated 2026-03-20.
Sponsored by Centre Hospitalier Universitaire Saint Pierre · Observational
In ageing populations, the main risk is the development of a syndrome of frailty, characterized by the addition of polymorbidity, polymedication, psychosocial difficulties, cognitive disorders, ... This functional decline is linked to a reduction in the person's functional reserves, and will lead to an increase in health problems, hospitalizations and, ultimately, mortality. People living with HIV (PLWH) over 50 develop the same kind of comorbidities as HIV-uninfected people over 75 years-old.
In Belgium, the care of PLWH\< 75 years with frailty syndrome is not reimbursed by healthcare insurance, and geriatric assessment and management is therefore not possible in this age group, despite the very real need.
Goals of this project are:
Projets proposal:
1,284 studies on the registry are indexed under Frailty; 452 are open to participants now.
This study's planned enrollment of 100 is below the median of 225 across 493 observational studies indexed under Frailty.
Browse Frailty studies →Centre Hospitalier Universitaire Saint Pierre is the lead sponsor of 78 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
all PLWH followed at the MIA center between 65 and 74 years included
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
number of PLWH between 65 and 74 years with frailty
Using Fried scale and complete geriatic assesment The Fried scale is a widely recognized assessment tool designed to evaluate frailty in older adults, particularly those aged 65 and above. It helps identify individuals at increased risk of adverse health outcomes, such as falls, hospitalization, disability, and mortality. The assessment is based on five key criteria: unintentional weight loss, exhaustion, low physical activity, slowness, and weakness, with each positive criterion scoring one point. Scores of 0 indicate a robust individual, 1-2 suggest a state of pre-frailty, and ≥3 confirm frailty.
Time frame: Baseline
Number of PLWH with a Fried test detecting frailty
Fried scale
Time frame: Baseline
Number of PLWH with Fried scale detecting pre-frailty condition
Fried scale
Time frame: Baseline
Results of Fried scale at one year
Fried scale performed one year after the first Fried scale in those with a abnormal Fried scale at baseline ( \>/=2)
Time frame: one year after the first Fried scale performed at baseline
Validate the application of the Fried scale in a population of PLWH
compared the number of the PLWH with an Fried scale of a score \>/= 2 and the number of PLWH with frailty assessed by a complete geriatrician estimation
Time frame: This analyse will be done at the end of the study when all patients will have complete the evaluation at one year.
Plan to share: No
Started Aug 2025 (actual). Primary completion is estimated for Jul 2028, 35 months after the start.
Of 289 non-industry observational studies under Frailty, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 55. This study's planned 35 months is above that.
Counting every sponsor, half of 292 studies reached it within 29 months; a quarter within 12 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire Saint Pierre